🇺🇸 FDA
Pipeline program

Silodosin

ECKIRB1020407

Phase 1 small_molecule completed

Quick answer

Silodosin for Benign Prostatic Hyperplasia is a Phase 1 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Benign Prostatic Hyperplasia
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials